Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer

被引:2
|
作者
Earle, Craig C. [1 ]
Weiser, Martin R. [2 ]
Ter Veer, Anna [3 ]
Skibber, John M. [4 ]
Wilson, John [5 ]
Rajput, Ashwani [6 ]
Wong, Yu-Ning [7 ]
Benson, Al B. [8 ]
Shibata, S. [3 ]
Romanus, Dorothy [9 ]
Niland, Joyce
Schrag, Deborah [3 ,9 ]
机构
[1] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] City Hope Canc Ctr, Duarte, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[7] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[8] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1002/jso.21549
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:644 / 644
页数:1
相关论文
共 50 条
  • [31] The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy
    Moug, Susan J.
    Oliphant, Raymond
    Balsitis, Margaret
    Molloy, Richard G.
    Morrison, David S.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (05) : 599 - 604
  • [32] Microsatellite Status and Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    de Gramont, Aimery
    Andre, Thierry
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (03) : 148 - 157
  • [33] Dilemma of Stage II Colon Cancer and Decision Making for Adjuvant Chemotherapy
    Fang, Sandy H.
    Efron, Jonathan E.
    Berho, Mariana E.
    Wexner, Steven D.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (05) : 1056 - 1069
  • [34] ADJUVANT CHEMOTHERAPY USE FOR STAGE II COLON CANCER IN MEDICARE POPULATION
    Jiao, X.
    Zhang, H.
    Barzi, A.
    VALUE IN HEALTH, 2018, 21 : S44 - S44
  • [35] Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
    O'Connor, Erin S.
    Greenblatt, David Yu
    LoConte, Noelle K.
    Gangnon, Ronald E.
    Liou, Jinn-Ing
    Heise, Charles P.
    Smith, Maureen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) : 3381 - 3388
  • [36] Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
    Karim, Safiya
    Booth, Christopher M.
    Brennan, Kelly
    Peng, Yingwei
    Siemens, D. Robert
    Krzyzanowska, Monika K.
    Mackillop, William J.
    CANCER MEDICINE, 2019, 8 (12): : 5590 - 5599
  • [37] The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy
    Susan J. Moug
    Raymond Oliphant
    Margaret Balsitis
    Richard G. Molloy
    David S. Morrison
    International Journal of Colorectal Disease, 2014, 29 : 599 - 604
  • [38] Utilization of adjuvant chemotherapy in "ideal candidates" with stage III colon cancer.
    Soleja, Mohsin
    Goksu, Suleyman Yasin
    Sanford, Nina Niu
    Beg, Muhammad Shaalan
    Kainthla, Radhika
    Sanjeevaiah, Aravind
    Jones, Amy Little
    Farkas, Linda
    Verma, Udit
    Hsieh, David
    Kazmi, Syed Mohammad Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period A SEER-Medicare Analysis
    Jiao, Xiayu
    Hay, Joel W.
    Sadeghi, Sarmad
    Barzi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 428 - 434
  • [40] Adjuvant chemotherapy of stage III colon cancer
    Benson, AB
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S74 - S77